Hedge Fund - Cryder Capital
Hca Healthcare Inc. (HCA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $227,657,309 | 11.26% | 841,057 | $247.16 |
| 2 | 2023 - Q3 (2023-09-30) | $225,837,190 | 10.91% | 918,112 | $273.63 |
| 3 | 2023 - Q2 (2023-06-30) | $279,499,921 | 13.62% | 920,983 | $278.02 |
| 4 | 2023 - Q1 (2023-03-31) | $243,631,355 | 12.95% | 923,966 | $254.01 |
| 5 | 2022 - Q4 (2022-12-31) | $223,769,659 | 13.83% | 932,529 | $223.97 |
| 6 | 2022 - Q3 (2022-09-30) | $205,621,000 | 12.75% | 1,118,782 | $199.21 |
| 7 | 2022 - Q2 (2022-06-30) | $188,251,000 | 10.27% | 1,120,142 | $214.83 |
| 8 | 2022 - Q1 (2022-03-31) | $259,859,000 | 12.76% | 1,036,864 | $251.12 |
| 9 | 2021 - Q4 (2021-12-31) | $288,192,000 | 13.04% | 1,121,719 | $244.70 |
| 10 | 2021 - Q3 (2021-09-30) | $272,264,000 | 13.59% | 1,121,719 | $244.48 |
| 11 | 2021 - Q2 (2021-06-30) | $231,904,000 | 12.05% | 1,121,719 | $203.81 |
| 12 | 2021 - Q1 (2021-03-31) | $179,404,000 | 12.82% | 952,555 | $176.34 |
| 13 | 2020 - Q4 (2020-12-31) | $160,416,000 | 12.81% | 975,411 | $146.22 |
| 14 | 2020 - Q3 (2020-09-30) | $118,707,000 | 11.03% | 952,090 | $123.78 |
| 15 | 2020 - Q2 (2020-06-30) | $78,374,000 | 8.48% | 807,483 | $103.96 |
| 16 | 2020 - Q1 (2020-03-31) | $72,552,000 | 10.57% | 807,483 | $129.47 |
| 17 | 2019 - Q4 (2019-12-31) | $132,549,000 | 15.03% | 896,753 | $134.29 |
| 18 | 2019 - Q3 (2019-09-30) | $107,987,000 | 13.86% | 896,753 | $129.24 |
| 19 | 2019 - Q2 (2019-06-30) | $110,235,000 | 16.3% | 815,527 | $126.43 |
| 20 | 2019 - Q1 (2019-03-31) | $90,037,000 | 13.84% | 690,574 | $134.31 |
| 21 | 2018 - Q4 (2018-12-31) | $85,271,000 | 15.52% | 685,182 | $134.22 |
| 22 | 2018 - Q3 (2018-09-30) | $107,098,000 | 16.47% | 769,824 | $124.49 |
| 23 | 2018 - Q2 (2018-06-30) | $85,738,000 | 14% | 835,656 | $101.18 |
| 24 | 2018 - Q1 (2018-03-31) | $51,156,000 | 14.69% | 527,386 | $97.03 |
| 25 | 2017 - Q4 (2017-12-31) | $44,571,000 | 14.36% | 507,406 | $80.34 |
| 26 | 2017 - Q3 (2017-09-30) | $29,339,000 | 11.97% | 368,626 | $80.42 |
| 27 | 2017 - Q2 (2017-06-30) | $37,511,000 | 13.75% | 368,626 | $84.60 |
| 28 | 2017 - Q1 (2017-03-31) | $32,804,000 | 13.3% | 368,626 | $83.38 |
| 29 | 2016 - Q4 (2016-12-31) | $28,249,000 | 12.61% | 381,646 | $74.89 |
| 30 | 2016 - Q3 (2016-09-30) | $23,788,000 | 13.94% | 314,531 | $76.57 |
| 31 | 2016 - Q2 (2016-06-30) | $18,321,000 | 14.69% | 237,901 | $78.94 |
| 32 | 2016 - Q1 (2016-03-31) | $16,778,000 | 12.84% | 214,967 | $69.83 |
| 33 | 2015 - Q4 (2015-12-31) | $14,967,000 | 12.56% | 221,303 | $69.75 |
| 34 | 2015 - Q3 (2015-09-30) | $15,343,000 | 9.91% | 198,336 | $88.55 |
| 35 | 2015 - Q2 (2015-06-30) | $15,250,000 | 11.05% | 168,096 | $80.12 |
The displayed share prices are average quarterly stock market prices.